Bettina Hansen, MSc, PhD

Follow Dr. Hansen:

Dr. Bettina Hansen studied statistics and mathematics at the Institute of Mathematical Statistics at the University of Copenhagen in Denmark. Next, she completed her PhD entitled 'Statistical models of treatment effects in chronic hepatitis B and C' in the Department of Gastroenterology and Hepatology at Erasmus University Medical Center (Erasmus MC) in the Netherlands.

Presently, she is a Senior Biostatistician in the Toronto Centre for Liver Disease at Toronto General Hospital and an Associate Professor in the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto. She also holds an academic appointment at Erasmus MC.

Together with the clinical research team, Dr. Hansen leads high-quality clinical research projects related to liver disease. The overall goal of her research program is to develop tools that can accurately identify patients who are at highest risk of experiencing disease progression or most likely to respond to treatment. To achieve this goal, she is developing individualized prediction models and dynamic scoring methods that can be applied in the daily medical practice.

In collaboration with national and international researchers, she has coordinated several global studies on antiviral treatment for viral hepatitis including HBV 99-01, VIRID, PARC, ARES, PEGON, GIANT-B, PAS, PEGON, the HCV Cohort Study and the Toronto Viral Hepatitis Care Network (VIRCAN). She also led the Global Primary Biliary Cholangitis (PBC) Group and the International Primary Sclerosis Cholangitis (PSC) study group, and initiated data registries for rare liver diseases in children (ie, NAPPED, GALA - projects). In Canada, she initiated the Canadian Network for Autoimmune Studies (CaNAL) which currenlty focuses on PBC and autoimmune hepatitis (AIH).

Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:95-106
Goet JC, Harms MH, Carbone M, Hansen BE
Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:1
van Buuren HR, Hansen BE
Gastroenterology. 2018 Oct 05;:
Montano-Loza AJ, Hansen BE, Corpechot C, Roccarina D, Thorburn D, Trivedi P, Hirschfield G, McDowell P, Poupon R, Dumortier J, Bosch A, Giostria E, Conti F, Parés A, Reig A, Floreani A, Russo FP, Goet J, Harms MH, van Buuren H, Van den Ende N, Nevens F...
Liver Transpl. 2018 Sep 28;:
Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M
J Viral Hepat. 2018 Sep 05;:
van Campenhout MJH, Brouwer WP, Xie Q, Guo S, Chi H, Qi X, Tabak F, Streinu-Cercel A, Wang JY, Zhang N, Idilman R, Reesink HW, Diculescu M, Simon K, Akdogan M, Mazur W, de Knegt RJ, Verhey E, Hansen BE, Janssen HLA, ARES Study Group
Gastroenterology. 2018 Jul 25;:
Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MC
Clin Gastroenterol Hepatol. 2018 Jun 11;:
Chi H, Li Z, Hansen BE, Yu T, Zhang X, Sun J, Hou J, Janssen HLA, Peng J
Hepatol Commun. 2018 Jun;2(6):683-692
Carbone M, Harms MH, Lammers WJ, Marmon T, Pencek R, MacConell L, Shapiro D, Jones DE, Mells GF, Hansen BE
J Surg Oncol. 2018 Jun 07;:
Sideras K, Galjart B, Vasaturo A, Pedroza-Gonzalez A, Biermann K, Mancham S, Nigg AL, Hansen BE, Stoop HA, Zhou G, Verhoef C, Sleijfer S, Sprengers D, Kwekkeboom J, Bruno MJ
J Clin Ultrasound. 2018 Jul;46(6):380-385
Taimr P, Klompenhouwer AJ, Thomeer MGJ, Hansen BE, Ijzermans JNM, de Man RA, de Knegt RJ


Associate Professor, Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto
Senior Biostatistician, Toronto Centre for Liver Disease, Toronto General Hospital
Senior Biostatistician and Associate Professor, Dept of Gastroenterology and Hepatology, Erasmus MC, the Netherlands